Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results
- PMID: 2948385
- DOI: 10.1016/0002-9343(86)90389-x
Characterization of a distinct subgroup of high-risk persons with Kaposi's sarcoma and good prognosis who present with normal T4 cell number and T4:T8 ratio and negative HTLV-III/LAV serologic test results
Abstract
Three homosexual male patients with biopsy-proved Kaposi's sarcoma were classified as having the acquired immune deficiency syndrome (AIDS) by Centers for Disease Control criteria when first seen in 1983 and 1984. These patients, however, differed from most patients with AIDS and Kaposi's sarcoma in having normal CD4 cell numbers and normal CD4:CD8 ratio. Furthermore, these immunologic parameters remained normal for eight to 24 months of follow-up, and the disease did not progress. Results of recent testing of serum from these patients were negative for HTLV-III/LAV antibodies. The Kaposi's sarcoma was limited to skin (stage I tumors) and the patients did not have persistent lymphadenopathy, fever, night sweats, or weight loss. In contrast to AIDS, the serum immunoglobulin levels (IgG, IgA, IgM) and number of B cells that were spontaneously forming immunoglobulin were within normal range with no evidence of polyclonal activation. The lymphocyte proliferative responses to phytohemagglutinin and Candida were reduced in two of the three patients, and skin test anergy was observed in the two patients tested. These findings are not frequently encountered in other healthy, homosexually active men or in classic Kaposi's sarcoma. They may be indicative of functional T cell changes (without numerical changes) induced by factors other than HTLV-III/LAV virus, which made these homosexually active men susceptible to development of low-grade Kaposi's sarcoma lesions.
Similar articles
-
Kaposi's sarcoma and HTLV-III: a study in Nigerian adult males.J R Soc Med. 1986 Sep;79(9):510-4. doi: 10.1177/014107688607900905. J R Soc Med. 1986. PMID: 3021963 Free PMC article.
-
Lymphadenopathic type of Kaposi's sarcoma in a Ugandan child seropositive for LAV/HTLV-III antibodies.J Trop Med Hyg. 1987 Apr;90(2):93-4. J Trop Med Hyg. 1987. PMID: 3470530
-
Prognostically significant classification of immune changes in AIDS with Kaposi's sarcoma.Blood. 1986 Mar;67(3):666-71. Blood. 1986. PMID: 3081065
-
Disseminated Kaposi's sarcoma not associated with HIV infection in a bisexual man.J Am Acad Dermatol. 1990 Nov;23(5 Pt 2):1035-8. doi: 10.1016/0190-9622(90)70332-c. J Am Acad Dermatol. 1990. PMID: 2229537 Review.
-
Unexplained persistent lymphadenopathy in homosexual men and the acquired immune deficiency syndrome.Medicine (Baltimore). 1985 May;64(3):203-13. doi: 10.1097/00005792-198505000-00005. Medicine (Baltimore). 1985. PMID: 3887096 Review.
Cited by
-
A critical analysis of the HIV-T4-cell-AIDS hypothesis.Genetica. 1995;95(1-3):5-24. doi: 10.1007/BF01434999. Genetica. 1995. PMID: 7744262 Review.
-
Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS).J Clin Immunol. 1987 Jan;7(1):16-23. doi: 10.1007/BF00915420. J Clin Immunol. 1987. PMID: 3104390
-
Long term survival of male homosexual patients with Kaposi's sarcoma.J R Soc Med. 1989 Apr;82(4):226-7. doi: 10.1177/014107688908200416. J R Soc Med. 1989. PMID: 2716022 Free PMC article. No abstract available.
-
Nonepidemic Kaposi sarcoma: A recently proposed category.JAAD Case Rep. 2017 Sep 3;3(5):441-443. doi: 10.1016/j.jdcr.2017.04.012. eCollection 2017 Sep. JAAD Case Rep. 2017. PMID: 28913409 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous